Formerly Summit Biosciences Inc. | KDD

Summit Biosciences Inc. has been acquired by Kindeva Drug Delivery, a global force in drug-device combination product development and manufacturing with expertise across pulmonary & nasal, injectable, and transdermal delivery. Summit brings its innovative nasal spray drug product capabilities to Kindeva, with the capacity to support any stage of product development, from conceptual to commercial, as well as our cGMP facility in Lexington, KY. Under Kindeva’s leadership, our dedicated and talented workforce will continue to drive our vision of increasing the availability of nasal drug-delivery options. For the most up-to-date information and news, please follow Kindeva’s page: https://www.linkedin.com/company/kindeva-drug-delivery/. To explore Kindeva’s leading drug-device CDMO capabilities and proactive, informed solutions, you can also visit www.kindevadd.com.  

网站

https://www.summitbiosciences.com/

Formerly Summit Biosciences Inc. | KDD的外部链接

所属行业

制药业

规模

1,001-5,000 人

总部

Lexington，KY

类型

私人持股

创立

2020

领域

Nasal Spray Drug Product Development、Nasal Spray Drug Product Manufacturing、ICH Stability Monitoring、CMC Regulatory Strategy、In-vitro bioequivalence studies、Formulation Development、Method Development & Validation和Drug Delivery Systems Development